What are the long-term symptoms and complications of COVID-19: a protocol for a living systematic review
Year: 2020
Type: review
Study design: Study Protocol
Abstract: Although the majority of people with Covid-19 will experience mild to moderate symptoms and will recover fully, there is now increasing evidence that a significant proportion will experience persistent symptoms for months after the acute phase of the illness. These symptoms include, among others, fatigue, problems breathing, lack of smell and taste, headaches, and depression and anxiety. It is also clear the virus has lasting fluctuating multiorgan sequelae, including affecting not only the respiratory system but also the heart, liver, and nervous system. We present a protocol for a living systematic review that aims to synthesize the evidence on the prevalence and characteristics of post-acute COVID-19. The living systematic review will be updated regularly, approximately every 6 months, as new evidence emerges. We will include studies that follow up at least 100 people with Covid-19 at 12 or more weeks post Covid-19 onset, with no restrictions regarding country, setting, or language. We will use descriptive statistics and, for outcomes reported in two or more studies, we will use meta-analyses to estimate prevalence with 95% confidence intervals (CIs) using the exact method. Heterogeneity between estimates will be assessed using the I2 statistic. Our findings will also be presented as infographics to facilitate transcription to lay audiences. Ultimately, we aim to support the work of policy makers, practitioners, and patients when planning rehabilitation for those recovering from Covid-19. The protocol has been registered with PROSPERO ( CRD42020211131, 25/09/2020).
Source: F1000Research
Authors: Melina Michelen, Vincent Cheng, Lakshmi Manoharan, Natalie Elkheir, Drew Dagens, Claire Hastie, Margaret O'Hara, Jake C. Suett, Dania Dahmash, Paulina Bugaeva, Ishmaela Rigby, Daniel Munblit, Eli Harriss, Amanda Burls, Carol Foote, Janet Scott, Gail Carson, Piero Olliaro, Louise Sigfrid, Charitini Stavropoulou
Institutions: University of London, City, University of London, University of Bristol, University of Oxford, London School of Hygiene & Tropical Medicine, Queen Elizabeth Hospital, Sechenov University, Moscow Research and Clinical Center for Neuropsychiatry, Imperial College London, MRC University of Glasgow Centre for Virus Research
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,350
Awards: G5122843612, ISARIC
OpenAlex ID: W3112436718
